Advances in antitumor effects using liposomal citrinin in induced breast cancer model

Detalhes bibliográficos
Autor(a) principal: Moura, Michely Laiany Vieira
Data de Publicação: 2024
Outros Autores: Menezes, Ag-Anne Pereira Melo de, Filho, José Williams Gomes de Oliveira, Nascimento, Maria Luiza Lima Barreto do, Reis, Antonielly Campinho dos, Ribeiro, Alessandra Braga, Silva, Felipe Cavalcanti Carneiro da, Nunes, Adriana Maria Viana, Rolim, Hercília Maria Lins, Cavalcante, Ana Amélia de Carvalho Melo, Sousa, João Marcelo de Castro e
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.14/43831
Resumo: The study aimed to evaluate the antitumor and toxicogenetic effects of liposomal nanoformulations containing citrinin in animal breast carcinoma induced by 7,12-dimethylbenzanthracene (DMBA). Mus musculus virgin females were divided into six groups treated with (1) olive oil (10 mL/kg); (2) 7,12-DMBA (6 mg/kg); (3) citrinin, CIT (2 mg/kg), (4) cyclophosphamide, CPA (25 mg/kg), (5) liposomal citrinin, LP-CIT (2 μg/kg), and (6) LP-CIT (6 µg/kg). Metabolic, behavioral, hematological, biochemical, histopathological, and toxicogenetic tests were performed. DMBA and cyclophosphamide induced behavioral changes, not observed for free and liposomal citrinin. No hematological or biochemical changes were observed for LP-CIT. However, free citrinin reduced monocytes and caused hepatotoxicity. During treatment, significant differences were observed regarding the weight of the right and left breasts treated with DMBA compared to negative controls. Treatment with CPA, CIT, and LP-CIT reduced the weight of both breasts, with better results for liposomal citrinin. Furthermore, CPA, CIT, and LP-CIT presented genotoxic effects for tumor, blood, bone marrow, and liver cells, although less DNA damage was observed for LP-CIT compared to CIT and CPA. Healthy cell damage induced by LP-CIT was repaired during treatment, unlike CPA, which caused clastogenic effects. Thus, LP-CIT showed advantages for its use as a model of nanosystems for antitumor studies.
id RCAP_ad73eddd3420caf3c671f6d4976c7712
oai_identifier_str oai:repositorio.ucp.pt:10400.14/43831
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Advances in antitumor effects using liposomal citrinin in induced breast cancer modelFungal metabolitesCytotoxicityNanotechnologyBreast cancerThe study aimed to evaluate the antitumor and toxicogenetic effects of liposomal nanoformulations containing citrinin in animal breast carcinoma induced by 7,12-dimethylbenzanthracene (DMBA). Mus musculus virgin females were divided into six groups treated with (1) olive oil (10 mL/kg); (2) 7,12-DMBA (6 mg/kg); (3) citrinin, CIT (2 mg/kg), (4) cyclophosphamide, CPA (25 mg/kg), (5) liposomal citrinin, LP-CIT (2 μg/kg), and (6) LP-CIT (6 µg/kg). Metabolic, behavioral, hematological, biochemical, histopathological, and toxicogenetic tests were performed. DMBA and cyclophosphamide induced behavioral changes, not observed for free and liposomal citrinin. No hematological or biochemical changes were observed for LP-CIT. However, free citrinin reduced monocytes and caused hepatotoxicity. During treatment, significant differences were observed regarding the weight of the right and left breasts treated with DMBA compared to negative controls. Treatment with CPA, CIT, and LP-CIT reduced the weight of both breasts, with better results for liposomal citrinin. Furthermore, CPA, CIT, and LP-CIT presented genotoxic effects for tumor, blood, bone marrow, and liver cells, although less DNA damage was observed for LP-CIT compared to CIT and CPA. Healthy cell damage induced by LP-CIT was repaired during treatment, unlike CPA, which caused clastogenic effects. Thus, LP-CIT showed advantages for its use as a model of nanosystems for antitumor studies.Veritati - Repositório Institucional da Universidade Católica PortuguesaMoura, Michely Laiany VieiraMenezes, Ag-Anne Pereira Melo deFilho, José Williams Gomes de OliveiraNascimento, Maria Luiza Lima Barreto doReis, Antonielly Campinho dosRibeiro, Alessandra BragaSilva, Felipe Cavalcanti Carneiro daNunes, Adriana Maria VianaRolim, Hercília Maria LinsCavalcante, Ana Amélia de Carvalho MeloSousa, João Marcelo de Castro e2024-02-05T12:41:11Z2024-01-262024-01-26T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.14/43831eng1999-492310.3390/pharmaceutics16020174info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-13T01:33:56Zoai:repositorio.ucp.pt:10400.14/43831Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:13:51.445164Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Advances in antitumor effects using liposomal citrinin in induced breast cancer model
title Advances in antitumor effects using liposomal citrinin in induced breast cancer model
spellingShingle Advances in antitumor effects using liposomal citrinin in induced breast cancer model
Moura, Michely Laiany Vieira
Fungal metabolites
Cytotoxicity
Nanotechnology
Breast cancer
title_short Advances in antitumor effects using liposomal citrinin in induced breast cancer model
title_full Advances in antitumor effects using liposomal citrinin in induced breast cancer model
title_fullStr Advances in antitumor effects using liposomal citrinin in induced breast cancer model
title_full_unstemmed Advances in antitumor effects using liposomal citrinin in induced breast cancer model
title_sort Advances in antitumor effects using liposomal citrinin in induced breast cancer model
author Moura, Michely Laiany Vieira
author_facet Moura, Michely Laiany Vieira
Menezes, Ag-Anne Pereira Melo de
Filho, José Williams Gomes de Oliveira
Nascimento, Maria Luiza Lima Barreto do
Reis, Antonielly Campinho dos
Ribeiro, Alessandra Braga
Silva, Felipe Cavalcanti Carneiro da
Nunes, Adriana Maria Viana
Rolim, Hercília Maria Lins
Cavalcante, Ana Amélia de Carvalho Melo
Sousa, João Marcelo de Castro e
author_role author
author2 Menezes, Ag-Anne Pereira Melo de
Filho, José Williams Gomes de Oliveira
Nascimento, Maria Luiza Lima Barreto do
Reis, Antonielly Campinho dos
Ribeiro, Alessandra Braga
Silva, Felipe Cavalcanti Carneiro da
Nunes, Adriana Maria Viana
Rolim, Hercília Maria Lins
Cavalcante, Ana Amélia de Carvalho Melo
Sousa, João Marcelo de Castro e
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Veritati - Repositório Institucional da Universidade Católica Portuguesa
dc.contributor.author.fl_str_mv Moura, Michely Laiany Vieira
Menezes, Ag-Anne Pereira Melo de
Filho, José Williams Gomes de Oliveira
Nascimento, Maria Luiza Lima Barreto do
Reis, Antonielly Campinho dos
Ribeiro, Alessandra Braga
Silva, Felipe Cavalcanti Carneiro da
Nunes, Adriana Maria Viana
Rolim, Hercília Maria Lins
Cavalcante, Ana Amélia de Carvalho Melo
Sousa, João Marcelo de Castro e
dc.subject.por.fl_str_mv Fungal metabolites
Cytotoxicity
Nanotechnology
Breast cancer
topic Fungal metabolites
Cytotoxicity
Nanotechnology
Breast cancer
description The study aimed to evaluate the antitumor and toxicogenetic effects of liposomal nanoformulations containing citrinin in animal breast carcinoma induced by 7,12-dimethylbenzanthracene (DMBA). Mus musculus virgin females were divided into six groups treated with (1) olive oil (10 mL/kg); (2) 7,12-DMBA (6 mg/kg); (3) citrinin, CIT (2 mg/kg), (4) cyclophosphamide, CPA (25 mg/kg), (5) liposomal citrinin, LP-CIT (2 μg/kg), and (6) LP-CIT (6 µg/kg). Metabolic, behavioral, hematological, biochemical, histopathological, and toxicogenetic tests were performed. DMBA and cyclophosphamide induced behavioral changes, not observed for free and liposomal citrinin. No hematological or biochemical changes were observed for LP-CIT. However, free citrinin reduced monocytes and caused hepatotoxicity. During treatment, significant differences were observed regarding the weight of the right and left breasts treated with DMBA compared to negative controls. Treatment with CPA, CIT, and LP-CIT reduced the weight of both breasts, with better results for liposomal citrinin. Furthermore, CPA, CIT, and LP-CIT presented genotoxic effects for tumor, blood, bone marrow, and liver cells, although less DNA damage was observed for LP-CIT compared to CIT and CPA. Healthy cell damage induced by LP-CIT was repaired during treatment, unlike CPA, which caused clastogenic effects. Thus, LP-CIT showed advantages for its use as a model of nanosystems for antitumor studies.
publishDate 2024
dc.date.none.fl_str_mv 2024-02-05T12:41:11Z
2024-01-26
2024-01-26T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/43831
url http://hdl.handle.net/10400.14/43831
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1999-4923
10.3390/pharmaceutics16020174
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137240944738304